Dicle Medical Journal
pISSN 1300-2945    eISSN 1308-9889
Archival Issues
Volume 38, 2011
Volume 37, 2010
Volume 36, 2009
Volume 35, 2008
Volume 34, 2007
Volume 33, 2006
Volume 32, 2005
Volume 31, 2004
Volume 30, 2003
Manuscript Submission
Copyright Transfer Agreement
Journal Abstract
Percutaneous closure of secundum atrial septal defects: Experience of a tertiary referral center
Oktay Ergene 1, Cem Nazlı 1, Uğur Kocabaş 1, Hamza Duygu 1, Nihan Kahya Eren 1, Zehra İlke Akyıldız 1, Ali Hikmet Kırdök 1, Rida Berilgen 1
1 - İzmir Atatürk Eğitim ve Araştırma Hastanesi, II. Kardiyoloji Kliniği, İzmir, Türkiye
Dicle Med J 2012; 39(1):97-101
ICID: 987030
Article type: Original article
IC™ Value: 3.00
Abstract provided by Publisher
Objectives: This study was aimed to evaluate our clinical
experiences and investigate results of percutaneous closure
of secundum atrial septal defects (ASD) in our clinic.
Results: We retrospectively included 70 patients (19
male, 51 female) undergoing percutaneous ASD closure
procedure with mean age of 36±14.8 (17-75) in our clinic
between March 2008 and January 2010. Defect diameter
measured by transesophageal echocardiography was
19.7±6.3 mm (6-32 mm). Device size used for percutaneous
closure of ASD was 23.7±6.2 (12-36). Devices used
for percutaneous closure were nitinol-based devices including
Amplatzer (64.7%), Cardiofix (26.7%) and biodegredable
BioStar (8.6%). The percutaneous closure
procedure was successful at 68 of 70 (97%) patients. In
2 patients procedure failed. Failure reason was device
embolization in one patient and device strut fracture in
other; so these 2 patients referred to surgery. During follow
up 2 more patients also referred to surgery because
of device embolization in first day control. In 3 patients
(4.2%) supraventricular arrythmias that are converted to
sinus by cardioversion are observed. Mean follow up interval
was 18.6±9.6 months (1-44) and during this period
peripheral vascular complications, cerebrovascular accidents,
thrombus on devices, device erosion or death is
not observed.
Conclusion: Percutaneous closure of secundum ASD
which started to replace surgical treatment of ASD in last
decades is safe and effective method in short to mid-term
period. However because of potentially serious complication
risks it should be performed in special centers by
operators who are experienced in treating structural heart

ICID 987030

Related articles
  • in IndexCopernicus™
         clinical outcome [2 related records]
         percutaneous closure [0 related records]
         atrial septal defect [8 related records]

    Comments: 0
    Published remarks are private opinions of the users.
    Editorial office of the service do not take responsibility for them.

    Copyright © Dicle Medical Journal   2019
    Page created by Index Copernicus Ltd. All Rights reserved.